Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
A [auth H]V-set_8e7k8rH1 A: beta sandwichesX: Immunoglobulin-like beta-sandwichH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: V-set_8ECOD (1.6)
A [auth H]C1-set_1e7k8rH2 A: beta sandwichesX: Immunoglobulin-like beta-sandwichH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: C1-set_1ECOD (1.6)
B [auth L]C1-set_4e7k8rL2 A: beta sandwichesX: Immunoglobulin-like beta-sandwichH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: C1-set_4ECOD (1.6)
B [auth L]V-sete7k8rL1 A: beta sandwichesX: Immunoglobulin-like beta-sandwichH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: V-setECOD (1.6)

IMGT Antibody Annotation IMGT Database Homepage

ChainProtein NameDescriptionOrganism NameGene Allele Name(s)Domain Name(s)Receptor TypeReceptor DescriptionProvenance Source
A [auth H]Fab C135, anti-SARS-CoV-2, neutralizing VH-CH1 Homo sapiens (human) IGHV3-30*01, IGHV3-30*04, IGHV3-30*07, IGHV3-30*11, IGHV3-30*14, IGHV3-30*16, IGHV3-30*17, IGHV3-30-3*01, IGHV3-30-3*02, IGHV3-30-3*03, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGHJ5*01, IGHJ8*01, IGHG1*03, IGHG1*08, IGHG1*06 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202415-0)
B [auth L]Fab C135, anti-SARS-CoV-2, neutralizing L-KAPPA Homo sapiens (human) IGKV1-5*01, IGKJ1*01, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202415-0)

SAbDab Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
A [auth H]Heavy ChainIGHV3 --SAbDab (2024-04-19)
B [auth L]Light ChainIGKV1 Kappa-SAbDab (2024-04-19)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
A [auth H] Ogalvibart SARS-CoV-2 Spike RBDTherapeutic SAbDab (2024-04-19)
B [auth L] Ogalvibart SARS-CoV-2 Spike RBDTherapeutic SAbDab (2024-04-19)